Pan‐cancer analysis shows that the expression of GABRP is tissue‐specific: it is significantly highly expressed in breast cancer, gastric cancer, and pancreatic cancer and is associated with immune microenvironment suppression and reduced survival rate, while in colorectal cancer, it may play a tumor suppressor role, suggesting that its function is cancer‐dependent. This evidence concerns the gene GABRP and breast carcinoma.